INS and type 2 diabetes mellitus: The early diagnosis of LADA or FT1D by appropriate screening methods, such as anti-islet autoantibodies as well as fasting c-peptide concentration in sera of T2D patients, can enhance treatment and potentially lead to methods to slow down the process of destruction against pancreatic β-cells with a possibility to delay or prevent insulin dependency.